Hemophilia a Trials in Valencia, Spain
Conditions / Hemophilia a / Valencia, Spain
Hemophilia a has been the subject of sustained clinical investigation across multiple research sites.
28 total trials for this combination
Showing top 10 of 28 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00884390 | Study Evaluating Safety Of Patients Switching To ReFacto AF In Usual Care Settings | TERMINATED | PHASE4 |
| NCT01945593 | BAX 855 Continuation | COMPLETED | PHASE3 |
| NCT02476942 | A Prospective Study to Collect High-Quality Documentation of Bleeds, Health-Related Quality of Life (HRQoL), and Safety Outcomes in Patients With Hemophilia A Treated With Standard-of-Care Treatment | COMPLETED | — |
| NCT01736475 | Study Investigating a PEGylated Recombinant Factor VIII (BAX 855) for Hemophilia A (PROLONG-ATE Study) | COMPLETED | PHASE2/PHASE3 |
| NCT00141843 | Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A | COMPLETED | PHASE3 |
| NCT02622321 | A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With Inhibitors | COMPLETED | PHASE3 |
| NCT00623727 | BAY79-4980 Compared to rFVIII-FS in Previously Treated Patients With Severe Hemophilia A | TERMINATED | PHASE2 |
| NCT01486927 | An Open-label Safety, Efficacy and Pharmacokinetic Study of a Recombinant FVIII Compared to Recombinant Human Antihemophilic FVIII in Patients With Severe Hemophilia A | COMPLETED | PHASE2/PHASE3 |
| NCT02172950 | An Open-label Safety and Efficacy Study of Recombinant FVIII in Patients With Severe Hemophilia A | COMPLETED | PHASE3 |
| NCT00357656 | Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery | COMPLETED | PHASE4 |